Event | 28 – 30 March, 2023

2023 Pharma Contract Manufacturing

Join us in Berlin

In the rapidly evolving contract manufacturing space, many of our customers have gained a competitive advantage by providing a better service to their sponsors. They have eliminated documents shared over email or shared Dropbox services and are securely sharing real-time batch data views.

Meet and speak to our experts to learn how our cloud-native Skyland PIMS software helps both sponsors and CMOs/CDMOs seamlessly share processes and process data in the same environment. Data can be securely and instantly shared while restricting visibility on a need-to-know basis. This single source of truth both speeds up and reduces risk to the tech transfer process, and its intended outcomes.

“We needed to move fast on our COVID-19 vaccine, replace Excel data management, and accelerate CMO data sharing, PIMS was the perfect product.” Director of Data and Analytics, Novavax

Hear Teodor Leahu speak about “Effective data sharing in external manufacturing networks” at 11:15 on March 29^th, 2023.

How cloud-based process information management systems improve collaboration and process performance
The role of digital data sharing in accelerating tech transfer and business and regulatory reporting, including cGMP CPV
Best practices to successfully engage and onboard your CMO for seamless data visibility

At our booth you can also learn more about how the process development capabilities of our BioPharma Lifecycle Management (BPLM) cloud platform, Polar, facilitates process data capture at its point of execution enabling process development scientists to design, run and analyze processes in a single platform for end-to-end visibility, traceability, optimization and AI/ML-powered insights.

For further information:

Learn more about Skyland PIMS and Polar.

Read “Accelerating Time-to-Insight Across the BioPharma Lifecycle” in BioPharm International, written by IDBS’ Pietro Forgione, Vice President of Strategy, to learn how a digital backbone is foundational in driving innovation.

Over time, insights driven by timely access to data also lead to better study design, which increases right-first-time development efforts and reduces the number of experiments needed.

We look forward to seeing you in Berlin!

About Pharma Contract Manufacturing: Europe’s Only Conference Focussed On Pinpointing Effective Solutions For Your Manufacturing Operations And Establishing Partnerships That Meet Your Organisation’s Needs, Now And For The Future. In this time of fast-moving shifts within the industry, increasing supply chain pressures and enhanced global demand for services, the pharma industry is continually looking to leverage external partnerships and engagements. With supply chain issues abound, increasing costs and lead times, coupled with the energy crisis, alongside ever-changing regulatory changes, it is necessary for manufacturers to determine where they outsource to and whom best to partner with. Against this backdrop and incorporating the current global environment – we have designed a detailed, informative and highly interactive three-day program that will exhibit a variety of case studies to provide the industry with copious opportunities to learn from each other’s experiences and find solutions to their current challenges. With various interactive sessions, thought-provoking workshops and unique opportunities to share knowledge and network with peers, join us for a leading community event where we look to resolve current challenges and determine best practices with the biggest and best leaders in the industry.

Meet the team

Teodor Leahu, Director of European Operations

Teodor has 14 years of expertise as a scientist in biotech process development, design, optimization and validation. His successful track record building and managing technology roadmaps for GMP manufacturing, including software selection, qualification and implementation, position him as a respected advisor on maximizing operational efficiency to accelerate scale-up, tech transfer and commercial release. Before joining IDBS, Teo served as Process Development Scientist at Emergent BioSolutions, where he led science and technology for a newly developed orphan disease vaccine. Previously at Merck Healthcare, his roles spanned Bioprocess Development Scientist and Compliance Specialist for Downstream Processing. Teo holds a BSc in Biomedical Engineering from Yale University and an MSc in Biotechnology and Bioengineering from EPFL (Swiss Federal Institute of Bioengineering).